These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1705274)

  • 1. Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen.
    Farinati F; Salvagnini M; de Maria N; Fornasiero A; Chiaramonte M; Rossaro L; Naccarato R
    J Hepatol; 1990 Nov; 11(3):297-301. PubMed ID: 1705274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma.
    Farinati F; De Maria N; Fornasiero A; Salvagnini M; Fagiuoli S; Chiaramonte M; Naccarato R
    Dig Dis Sci; 1992 May; 37(5):659-62. PubMed ID: 1373360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma.
    Martínez Cerezo FJ; Tomás A; Donoso L; Enríquez J; Guarner C; Balanzó J; Martínez Nogueras A; Vilardell F
    J Hepatol; 1994 Jun; 20(6):702-6. PubMed ID: 7930468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma.
    Elba S; Giannuzzi V; Misciagna G; Manghisi OG
    Ital J Gastroenterol; 1994 Mar; 26(2):66-8. PubMed ID: 8032079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study.
    Liu CL; Fan ST; Ng IO; Lo CM; Poon RT; Wong J
    Am J Gastroenterol; 2000 Jan; 95(1):218-22. PubMed ID: 10638587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatocellular carcinoma (HCC): the long-term response to tamoxifen. A clinical case report and review of the literature].
    Recchia F; Passalacqua G; Rodorigo C; Belli L; Morgante A; Rabitti G
    Minerva Med; 1989 Dec; 80(12):1363-6. PubMed ID: 2560153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
    Barbare JC; Bouché O; Bonnetain F; Raoul JL; Rougier P; Abergel A; Boige V; Denis B; Blanchi A; Pariente A; Milan C; Bedenne L
    J Clin Oncol; 2005 Jul; 23(19):4338-46. PubMed ID: 15994145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients.
    Lencioni R; Bartolozzi C; Caramella D; Paolicchi A; Carrai M; Maltinti G; Capria A; Tafi A; Conte PF; Bevilacqua G
    Cancer; 1995 Nov; 76(10):1737-46. PubMed ID: 8625042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regression of hepatocellular carcinoma under Tamoxifen: report of one case and review of the literature].
    Macaigne G; Auriault ML; Boivin JF; Cheaib S; Chayette C; Deplus R
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1165-7. PubMed ID: 12520204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. CLIP Group (Cancer of the Liver Italian Programme).
    Lancet; 1998 Jul; 352(9121):17-20. PubMed ID: 9800740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma.
    Cheng AL; Yeh KH; Fine RL; Chuang SE; Yang CH; Wang LH; Chen DS
    Hepatogastroenterology; 1998; 45(24):1955-60. PubMed ID: 9951847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients.
    Castells A; Bruix J; Brú C; Ayuso C; Roca M; Boix L; Vilana R; Rodés J
    Gastroenterology; 1995 Sep; 109(3):917-22. PubMed ID: 7657122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
    Doffoël M; Bonnetain F; Bouché O; Vetter D; Abergel A; Fratté S; Grangé JD; Stremsdoerfer N; Blanchi A; Bronowicki JP; Caroli-Bosc FX; Causse X; Masskouri F; Rougier P; Bedenne L;
    Eur J Cancer; 2008 Mar; 44(4):528-38. PubMed ID: 18242076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
    Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
    Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma.
    Riestra S; Rodriguez M; Delgado M; Suárez A; González N; de la Mata M; Diaz G; Miño-Fugarolas G; Rodrigo L
    J Clin Gastroenterol; 1998 Apr; 26(3):200-3. PubMed ID: 9600369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial.
    Perrone F; Gallo C; Daniele B; Gaeta GB; Izzo F; Capuano G; Adinolfi LE; Mazzanti R; Farinati F; Elba S; Piai G; Calandra M; Stanzione M; Mattera D; Aiello A; De Sio I; Castiglione F; Russo M; Persico M; Felder M; Manghisi OG; De Maio E; Di Maio M; Pignata S;
    Curr Pharm Des; 2002; 8(11):1013-9. PubMed ID: 11945148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
    Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled clinical trial of doxorubicin and tamoxifen versus tamoxifen monotherapy in hepatocellular carcinoma.
    Schachschal G; Lochs H; Plauth M
    Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):281-4. PubMed ID: 10750647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of tamoxifen in hepatocellular carcinoma.
    Engstrom PF; Levin B; Moertel CG; Schutt A
    Cancer; 1990 Jun; 65(12):2641-3. PubMed ID: 2160313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.
    Pan DY; Qiao JG; Chen JW; Huo YC; Zhou YK; Shi HA
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):211-5. PubMed ID: 14599971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.